Keyrus SA (ALKEY)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 7.720 |
|---|---|
| 52-week range | 6.780 – 9.840 |
| Return, 1 month / 3 months | −4.7% / +1.8% |
| Return, 1 year / 3 years | +7.5% / +24.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 40 |
| Volatility (1 year) | 28.7% |
| Worst drawdown (1 year) | -25.2% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Keyrus is a consulting company that helps organisations make use of their data and modernise their digital operations. It offers services in data intelligence, analytics, business intelligence and performance management, along with digital and technology consulting. Its customers are mainly large companies and public organisations across sectors such as retail, banking, industry and healthcare. The firm is based in France and works with clients internationally through its network of offices and subsidiaries.
Keyrus SA trades under the code ALKEY on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Keyrus SA (ALKEY) trades on the Euronext Paris in France. It last closed at EUR 7.720 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 107 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.5% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 0.9% | ||
| From 52-week high | -15.5% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | 6.3% | ||
| 12-month return, skipping the last month | 12.8% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.2% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | −4.7% |
| 3 months | +1.8% |
| 6 months | +6.3% |
| 1 year | +7.5% |
| 3 years | +24.5% |
| 5 years | +114.4% |
Signals
| 50-day / 200-day average | 7.977 / 7.653 |
|---|---|
| Golden / death cross (60 days) | Golden, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.081 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.